Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Organovo Holdings Inc (ONVO)

NASDAQ
Currency in USD
Disclaimer
0.443
-0.015(-4.37%)
Closed
After Hours
0.462+0.019(+4.289%)
ONVO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.4400.458
52 wk Range
0.4302.050
Prev. Close
0.443
Open
0.45
Day's Range
0.44-0.458
52 wk Range
0.43-2.05
Volume
17,635
Average Volume (3m)
97,587
1-Year Change
-64.56%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ONVO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Organovo Holdings Company Profile

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company’s lead candidate is FXR314, which is phase 2/3 clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus on non-alcoholic steatohepatitis and primary biliary cholangitis. It has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California.

Compare ONVO to Peers and Sector

Metrics to compare
ONVO
Peers
Sector
Relationship
P/E Ratio
−0.5x−4.5x−0.6x
PEG Ratio
−0.01−0.060.00
Price/Book
1.0x2.7x2.6x
Price / LTM Sales
93.2x8.4x3.2x
Upside (Analyst Target)
-139.8%48.5%
Fair Value Upside
Unlock28.4%7.8%Unlock

FAQ

What Is the Organovo Holdings (ONVO) Stock Price Today?

The Organovo Holdings stock price today is 0.443.

What Stock Exchange Does Organovo Holdings Trade On?

Organovo Holdings is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Organovo Holdings?

The stock symbol for Organovo Holdings is "ONVO."

What Is the Organovo Holdings Market Cap?

As of today, Organovo Holdings market cap is 6.81M.

What is Organovo Holdings Earnings Per Share?

The Organovo Holdings EPS is -1.32.

What Is the Next Organovo Holdings Earnings Date?

Organovo Holdings will release its next earnings report on 06 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.